Drug Conjugates for Targeting Eph Receptors in Glioblastoma

Glioblastoma (GBM) is a complex and heterogeneous tumor that warrants a comprehensive therapeutic approach for treatment. Tumor-associated antigens offer an opportunity to selectively target various components of the GBM microenvironment while sparing the normal cells within the central nervous syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Puja, Roberts, Callie, Herpai, Denise, Fokt, Izabela D., Priebe, Waldemar, Debinski, Waldemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243104/
https://www.ncbi.nlm.nih.gov/pubmed/32340173
http://dx.doi.org/10.3390/ph13040077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243104/
https://www.ncbi.nlm.nih.gov/pubmed/32340173
http://dx.doi.org/10.3390/ph13040077

Ejemplares similares